methanesulfonic acid 3-(5-methyl-2-phenyl-oxazol-4-yl)-propyl ester | 331746-28-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: methanesulfonic acid 3-(5-methyl-2-phenyl-oxazol-4-yl)-propyl ester
• 英文别名: 3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propyl methanesulfonate
• CAS: 331746-28-2
• 化学式: C₁₄H₁₇NO₄S
• 分子量: 295.359
• InChiKey: RKZMAHQBTQKIBE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  20
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  77.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  rac-2-Ethoxy-3-(2-methyl-1H-indol-5-yl)-propionic acid ethyl ester 、 methanesulfonic acid 3-(5-methyl-2-phenyl-oxazol-4-yl)-propyl ester 以to give rac-2-ethoxy-3-{2-methyl-1-[3-(5-methyl-2-phenyl-oxazol-4-yl)-propyl]-1H-indol-5-yl}-propionic acid as orange viscous oil的产率得到rac-2-ethoxy-3-{2-methyl-1-[3-(5-methyl-2-phenyl-oxazol-4-yl)-propyl]-1H-indol-5-yl}-propionic acid
  参考文献：
  名称：

  Indolyl derivatives

  摘要：

  提供了式I的化合物，以及其药学上可接受的盐和酯，其中R1至R8、A、A1和n的含义如规范中所示。

  公开号：

  US20040053979A1

文献信息

• [EN] CHROMAN CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES AND LIPID DISORDERS<br/>[FR] DERIVES D'ACIDE CHROMANCARBOXYLIQUE UTILISES DANS LE TRAITEMENT DU DIABETE ET DES TROUBLES LIPIDIQUES
  申请人：SK CORP

  公开号：WO2005021540A1

  公开（公告）日：2005-03-10

  The invention is concerned with the 3-chromancarboxylic acid derivatives, their pharmaceutically acceptable salts and prodrugs which are useful for treatment and control of non-insulin dependent diabetes mellitus (type II diabetes) and its related vascular disease as well as obesity and lipid disorders.

  这项发明涉及3-色胺羧酸衍生物，它们的药用盐和前药，用于治疗和控制非胰岛素依赖型糖尿病（2型糖尿病）及其相关血管疾病，以及肥胖和脂质紊乱。
• Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
  申请人：Choi Moon Yong

  公开号：US20050107371A1

  公开（公告）日：2005-05-19

  There are disclosed derivatives of 3-chromancarboxylic acid represented by formula I their pharmaceutically acceptable salts thereof and prodrugs thereof which are useful for treatment and control of non-insulin dependent diabetes mellitus (type II diabetes) and its related vascular disease as well as obesity and lipid disorders

  本发明公开了3-香豆酸衍生物，其化学式为I，以及其药学上可接受的盐和前药。这些衍生物对治疗和控制非胰岛素依赖性糖尿病（2型糖尿病）及其相关的血管疾病、肥胖和脂质紊乱具有用处。
• Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
  申请人：Cheng T. Peter

  公开号：US20070015797A1

  公开（公告）日：2007-01-18

  Compounds are provided which have the structure wherein Q is C or N, A is O or S, Z is O or a bond, X is CH or N and R 1 , R 2 , R 2a , R 2b , R 2c , R 3 , Y, x, m, and n are as defined herein, which compounds are useful as antidiabetic, hypolipidemic, and antiobesity agents.

  提供了一些化合物，它们的结构如下：其中Q为C或N，A为O或S，Z为O或键，X为CH或N，R1、R2、R2a、R2b、R2c、R3、Y、x、m和n如此定义，这些化合物可用作抗糖尿病、降脂和抗肥胖药物。
• N-SUBSTITUTED-1H-INDOL-5-PROPIONIC ACID COMPOUNDS AS PPAR AGONISTS USEFUL FOR THE TREATMENT OF DIABETES
  申请人：F. Hoffmann-La Roche AG

  公开号：EP1539746A1

  公开（公告）日：2005-06-15
• INDOLYL DERIVATIVES
  申请人：F.HOFFMANN-LA ROCHE AG

  公开号：EP1567523A1

  公开（公告）日：2005-08-31